These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of tetracyclines in rosacea. Alikhan A; Kurek L; Feldman SR Am J Clin Dermatol; 2010; 11(2):79-87. PubMed ID: 20141228 [TBL] [Abstract][Full Text] [Related]
3. Tetracyclines: nonantibiotic properties and their clinical implications. Sapadin AN; Fleischmajer R J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056 [TBL] [Abstract][Full Text] [Related]
5. PCR analysis for Wolbachia in human and canine Demodex mites. Borgo SN; Sattler EC; Hogardt M; Adler K; Plewig G Arch Dermatol Res; 2009 Oct; 301(10):747-52. PubMed ID: 19652990 [TBL] [Abstract][Full Text] [Related]
6. [Physiopathology of rosacea. Redness, telangiectasia, and rosacea]. Cribier B Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S129-37. PubMed ID: 21907872 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Cribier B Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S184-91. PubMed ID: 22183097 [TBL] [Abstract][Full Text] [Related]
8. Ocular rosacea: an update on pathogenesis and therapy. Stone DU; Chodosh J Curr Opin Ophthalmol; 2004 Dec; 15(6):499-502. PubMed ID: 15523195 [TBL] [Abstract][Full Text] [Related]
9. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. Fowler JF J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530 [TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species and rosacea. Jones D Cutis; 2004 Sep; 74(3 Suppl):17-20, 32-4. PubMed ID: 15499754 [TBL] [Abstract][Full Text] [Related]
11. Use of macrolides and tetracyclines for chronic inflammatory diseases. Voils SA; Evans ME; Lane MT; Schosser RH; Rapp RP Ann Pharmacother; 2005 Jan; 39(1):86-94. PubMed ID: 15562139 [TBL] [Abstract][Full Text] [Related]
12. Emerging therapies in rosacea. Layton A; Thiboutot D J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S57-65. PubMed ID: 24229638 [TBL] [Abstract][Full Text] [Related]
13. Rosacea: I. Etiology, pathogenesis, and subtype classification. Crawford GH; Pelle MT; James WD J Am Acad Dermatol; 2004 Sep; 51(3):327-41; quiz 342-4. PubMed ID: 15337973 [TBL] [Abstract][Full Text] [Related]
14. The pathophysiology of rosacea. Mc Aleer MA; Lacey N; Powell FC G Ital Dermatol Venereol; 2009 Dec; 144(6):663-71. PubMed ID: 19907405 [TBL] [Abstract][Full Text] [Related]
16. Rosacea: an update. Buechner SA Dermatology; 2005; 210(2):100-8. PubMed ID: 15724091 [TBL] [Abstract][Full Text] [Related]
17. Subantimicrobial dose doxycycline for acne and rosacea. Bikowski JB Skinmed; 2003; 2(4):234-45. PubMed ID: 14673277 [TBL] [Abstract][Full Text] [Related]
18. Inflammation in rosacea and acne: Implications for patient care. Fleischer AB J Drugs Dermatol; 2011 Jun; 10(6):614-20. PubMed ID: 21961194 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Webster GF; Toso SM; Hegemann L Arch Dermatol; 1994 Jun; 130(6):748-52. PubMed ID: 8002645 [TBL] [Abstract][Full Text] [Related]
20. Demodicosis: a clinicopathological study. Hsu CK; Hsu MM; Lee JY J Am Acad Dermatol; 2009 Mar; 60(3):453-62. PubMed ID: 19231642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]